Every Form 4 that UnitedHealth Group Incorporated (UNH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow UNH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full UNH filings page.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On June 5, 2026, 686.861 shares of common stock were withheld at $399.47 per share to cover tax obligations, leaving him with 16,914.309 directly held shares.
UnitedHealth Group executive Christopher R. Zaetta reported a small, routine tax-related share disposition. On this Form 4, he used 134.02 shares of UnitedHealth Group common stock, valued at $377.00 per share, to satisfy tax obligations. After this tax-withholding disposition, he continues to hold 16,582.149 shares directly, indicating the transaction affects only a minor portion of his overall position and does not represent an open-market sale.
UNITEDHEALTH GROUP executive Patrick Hugh Conway, Chief Executive Officer of Optum, used company shares to cover tax obligations on equity compensation. A total of 203.821 shares of common stock were disposed of at $377.92 per share, leaving him with 17,601.17 shares held directly.
UnitedHealth Group executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported an open-market sale of 800 shares of UnitedHealth Group common stock. The shares were sold at a price of $355.00 per share. After this transaction, he directly holds 17,804.991 shares of common stock.
HOOPER MICHELE J reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Michele J. Hooper received a grant of 206 deferred stock units of common stock on April 1, 2026 as regular quarterly compensation for Board service. The units are immediately vested but must be held until her Board service ends, bringing her direct holdings to 41,792 shares/units. This is a routine compensation-related equity award rather than an open-market purchase or sale.
MCNABB FREDERICK WILLIAM III reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant of 388 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until he completes his service on the Board, and his direct holdings after the award total 15,162 shares.
Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Charles D. Baker received 343 deferred stock units of Common Stock as part of his regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board, bringing his direct holdings to 2,163 shares.
Gil Kristen reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Kristen Gil received 320 deferred stock units of common stock as regular quarterly compensation for Board service. These units are immediately vested but must be held until her Board service ends. Following this grant, she holds 2,403 shares directly and 3,800 shares indirectly through a trust.
Noseworthy John H reported acquisition or exercise transactions in this Form 4 filing.
Director John H. Noseworthy received a grant of 320 deferred stock units of UnitedHealth Group common stock as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board. Following this award, he directly holds 7,369 shares of common stock.
UnitedHealth Group director Paul R. Garcia reported routine equity compensation awards. On April 1, 2026, he acquired 206 deferred stock units and 137 shares of common stock as regular quarterly compensation for Board service. The deferred stock units are immediately vested but must be held until he completes Board service.
After these awards, Garcia directly holds 3,673 shares of UnitedHealth Group common stock. He also has indirect holdings through trusts, including 2,146 shares by a revocable trust, 45 shares by Trust 2, and 55 shares by Trust 3, reflecting additional beneficial interests reported in this filing.
Gottlieb Scott reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Scott Gottlieb received a grant of 320 deferred stock units of Common Stock as regular quarterly board compensation. The units are immediately vested but must be held until he completes his service on the Board. Following this award, he directly holds 446 shares/units in total.
MONTGOMERY RICE VALERIE MD reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice, MD, received an award of 343 deferred stock units of common stock as regular quarterly compensation for Board service. The units are immediately vested but must be held until she completes her Board service. Following this grant, she directly holds 7,615 shares/units.
FLYNN TIMOTHY PATRICK reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group director Timothy Patrick Flynn received a grant of 350 shares of Common Stock-equivalent deferred stock units on April 1 as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be retained until he completes his service on the Board.
Following this grant, Flynn directly holds 10,589 shares of UnitedHealth Group common stock. In addition, an indirect holding entry reflects 6,033 shares held by a trust, indicating a separate ownership structure for part of his overall position.
UNITEDHEALTH GROUP INC director Valerie Montgomery Rice received 53 shares of Common Stock as a grant. The Form 4 shows this as a compensation-related acquisition, with no purchase price. The footnote explains these are dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this grant, her directly held Common Stock totals 7,272 shares.
UNITEDHEALTH GROUP INC Chief Financial Officer Wayne S. DeVeydt reported an automatic stock-based award rather than a market trade. He acquired 149.989 shares of common stock at a stated price of $0.0000 per share, increasing his direct holdings to 19,666.93 shares.
According to the footnote, these shares represent dividend equivalents paid on outstanding restricted stock units. The dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine compensation-related accrual rather than an open-market purchase or sale.
UNITEDHEALTH GROUP INC Chief Accounting Officer Dennis Andrew Stankiewicz reported an acquisition of common stock tied to existing equity awards. On March 17, 2026, he received 68.058 shares of common stock at no cost as dividend equivalents on outstanding restricted stock units, which are subject to the same vesting conditions and are forfeited if the underlying units do not vest. Following this award, his directly held common stock position increased to 10,205.939 shares, indicating a routine compensation-related update rather than an open-market trade.
UnitedHealth Group director Paul R. Garcia received an equity-based award linked to existing deferred stock units. On March 17, 2026, he acquired 16 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units that are immediately vested and subject to the same terms as the underlying units.
Following this grant, Garcia directly holds 3,330 shares of UnitedHealth Group common stock. He also has indirect holdings reported through a revocable trust and additional trusts, reflecting shares held in estate-planning vehicles rather than through open‑market transactions.
UNITEDHEALTH GROUP INC director John H. Noseworthy received 52 shares of common stock as a grant tied to dividend equivalents on vested deferred stock units. The shares were acquired at no cost, are immediately vested, and follow the same terms as the underlying deferred stock units. After this award, he directly holds 7,049 shares of common stock.
UNITEDHEALTH GROUP INC executive Christopher R. Zaetta received additional common stock linked to existing equity awards. On March 17, 2026, he acquired 89.629 shares of Common Stock at a stated price of $0.00 per share, reported as a grant or award acquisition.
The footnote explains this represents dividend equivalents paid on outstanding restricted stock units. These dividend equivalents follow the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. After this transaction, Zaetta directly holds 16,716.169 shares of Common Stock.
UNITEDHEALTH GROUP INC executive Timothy John Noel, Chief Executive Officer of UnitedHealthcare, received an acquisition of 102.329 shares of common stock as of March 17, 2026. These shares represent dividend equivalents on outstanding restricted stock units and are granted at no cash cost to him.
After this award, his directly held common stock position reported in this filing increased to 17,574.653 shares. The dividend equivalents are subject to the same vesting conditions as the underlying restricted stock units and will be forfeited if those units do not vest, making this a routine, compensation-related equity accrual rather than an open‑market purchase.
UNITEDHEALTH GROUP INC director Frederick William McNabb III reported an automatic share-based compensation event. He acquired 64 shares of common stock on March 17, 2026 with a reported price of $0.0000 per share, described as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units. After this credit, his directly held common stock position increased to 14,774 shares, reflecting a small, routine adjustment rather than an open-market purchase.
UnitedHealth Group director Timothy Patrick Flynn reported a small stock award tied to existing deferred compensation. On March 17, 2026, he acquired 79 shares of UnitedHealth common stock at $0.0000 per share as dividend equivalents on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. Following this grant, his direct holdings total 10,239 shares of common stock, and he also holds 6,033 shares indirectly through a trust.
HEMSLEY STEPHEN J reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC director and CEO Stephen J. Hemsley received an award of 61 shares of common stock on March 17, 2026. This was reported as a grant or award of dividend equivalents on vested deferred stock units at a stated price of $0.0000 per share, and the dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units.
After this transaction, Hemsley directly holds 362,628.942 shares of common stock. He also has indirect holdings of 355.091 shares through a 401(k) plan and 692,255 shares held by trusts, which include 10,380 shares previously held directly and contributed to the trusts on January 29, 2026 in a transaction noted as exempt from reporting pursuant to Rule 16a-13.
UNITEDHEALTH GROUP INC director Charles D. Baker reported a small share award. On March 17, 2026, he acquired 14 shares of Common Stock at a price of $0.00 per share as a grant/award acquisition.
According to the footnote, these shares represent dividend equivalents paid on vested deferred stock units, which are immediately vested and subject to the same terms as the underlying deferred stock units. After this transaction, Baker directly holds 1,820 shares of UnitedHealth Group common stock.
UNITEDHEALTH GROUP INC executive Erin McSweeney, EVP & Chief People Officer, reported an acquisition of company common stock through a share-based award. She received 64.885 shares as dividend equivalents on outstanding restricted stock units at a stated price of $0.00 per share.
These dividend equivalents are subject to the same vesting terms as the underlying restricted stock units and will be forfeited if those units do not vest. Following this award, McSweeney directly holds a reported total of 15,552.923 UnitedHealth Group common shares.
UNITEDHEALTH GROUP INC director Michele J. Hooper received 292 shares of common stock as dividend equivalents on vested deferred stock units. These dividend equivalents are immediately vested and follow the same terms as the underlying deferred stock units, meaning they function as routine, compensation-related accruals rather than an open-market purchase. After this acquisition, Hooper directly holds a total of 41,586 shares of UnitedHealth Group common stock, indicating this is a small, incremental increase to an existing position.
UNITEDHEALTH GROUP INC director Kristen Gil reported a small stock award. On March 17, 2026, Gil acquired 8 shares of common stock at $0.00 per share, described as dividend equivalents paid on vested deferred stock units and subject to the same terms as those units. After this award, Gil holds 2,083 shares directly and 3,800 shares indirectly through a trust, indicating this is a routine, compensation-related update rather than an open-market trade.
UNITEDHEALTH GROUP INC director Scott Gottlieb reported a small compensation-related equity acquisition. He received 1 share-equivalent of common stock on 2026-03-17 as dividend equivalents paid on vested deferred stock units, which are immediately vested and follow the same terms as the underlying units. After this award, he directly owns 126 shares of common stock.
Conway Patrick Hugh reported acquisition or exercise transactions in this Form 4 filing.
UNITEDHEALTH GROUP INC reported that Patrick Hugh Conway, Chief Executive Officer of Optum, received a grant of 125.021 shares of common stock on March 17, 2026 at a price of $0.00 per share. These shares represent dividend equivalents on his outstanding restricted stock units and will vest or be forfeited under the same conditions as those units. Following this award, his directly held common stock position increased to 18,604.991 shares, indicating a routine, compensation-related adjustment rather than an open-market purchase.
UNITEDHEALTH GROUP INC Chief Accounting Officer Thomas E. Roos reported several equity-related transactions on common stock and options. He was granted 9,768 non-qualified stock options with an exercise right to buy shares, all recorded at a price of $0.0000 per option. He also acquired 2,436 shares of common stock through a grant or award and had 151.777 shares of common stock disposed of to cover tax obligations at $282.3400 per share. Following these transactions, his directly held common stock position increased to 31,283.641 shares. The non-qualified stock options vest 25% each year on February 23 from 2027 through 2030, and restricted stock units referenced in the footnotes vest on the same schedule.
UnitedHealth Group executive Christopher R. Zaetta received new equity awards, including 28,414 non-qualified stock options with a $282.34 per-share exercise price expiring on February 23, 2036, and a grant of 7,084 shares of common stock. On the same date, 129.454 common shares were delivered to cover tax liabilities. Following these transactions, he directly holds 16,626.54 shares of UnitedHealth common stock. Footnotes state that restricted stock units and the non-qualified options vest 25% annually each February 23 from 2027 through 2030.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported new equity awards and a small tax-related share disposition. He received 35,517 non-qualified stock options and 8,855 shares of common stock as grants. The options and the related restricted stock units vest 25% each year on February 23 from 2027 through 2030. To satisfy tax obligations, 123.171 shares of common stock were disposed of at $282.34 per share, leaving him with 17,472.324 common shares directly owned.
UNITEDHEALTH GROUP executive Erin McSweeney reported new equity awards and a related tax share disposition. She was granted 19,535 non-qualified stock options with an exercise right, and 4,871 shares of common stock as a stock award. The filing also shows 130.684 shares of common stock were disposed of at $282.34 per share to satisfy tax withholding obligations. Both the restricted stock units referenced in the footnotes and the non-qualified stock options vest 25% each year on February 23 from 2027 through 2030, spreading the compensation over four years.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported equity compensation and a related tax share disposition. He was granted 35,517 non-qualified stock options with an exercise right to buy shares, and 8,855 shares of common stock as a stock award. Both awards vest in four equal installments of 25% on February 23 of each year from 2027 through 2030. To satisfy tax obligations on equity, 178.988 shares of common stock were disposed of at $282.34 per share, leaving him with 18,479.97 common shares held directly after these transactions.
DeVeydt Wayne S reported acquisition or exercise transactions in this Form 4 filing.
UnitedHealth Group’s Chief Financial Officer Wayne S. DeVeydt reported equity awards that increase his direct ownership in the company. He was granted non-qualified stock options for 35,517 shares on February 23, 2026, and a separate award of 8,855 shares of common stock at $282.34 per share.
The common stock award and related restricted stock units vest in 25% increments each February 23 from 2027 through 2030. The stock options follow the same vesting schedule, also vesting 25% annually on those dates. These awards are classified as grants or awards rather than open-market purchases.
UnitedHealth Group executive Erin McSweeney reported two insider transactions involving company common stock. On February 20, 2026, she disposed of 136.641 shares and 155.182 shares at $290.00 per share, both coded as F transactions, meaning shares were withheld to cover tax liabilities rather than sold on the open market.
UnitedHealth Group executive Christopher R. Zaetta reported two tax-related share dispositions. On February 20, 2026, he surrendered 130.851 and 312.436 shares of UnitedHealth common stock at a stated value of $290 per share to cover taxes by delivering shares rather than paying cash.
After these withholding transactions, his directly held balances reported in the filing were 9,984.430 shares following the first disposition and 9,671.994 shares following the second, reflecting routine administrative adjustments tied to equity compensation.
UNITEDHEALTH GROUP INC executive Patrick Hugh Conway, Chief Executive Officer of Optum, reported two Form 4 transactions involving common stock. On February 20, 2026, he disposed of 249.6400 and 254.9080 shares at $290.00 per share as tax-withholding dispositions, meaning shares were withheld to cover tax obligations rather than sold on the open market. After these transactions, his directly owned common stock holdings were reported at 9,803.9580 shares.
UNITEDHEALTH GROUP INC executive Timothy John Noel reported tax-related share dispositions under a Form 4. On February 20, 2026, he used 152.599 and 311.958 shares of common stock, each at $290.00 per share, to cover tax obligations. After these non-market transactions, he directly owned 8,740.495 common shares.
UnitedHealth Group Chief Accounting Officer Thomas E. Roos reported two tax-withholding share dispositions tied to equity compensation. On February 20, 2026, he surrendered a total of 326.067 shares of common stock in transactions coded “F” at $290.0000 per share to cover tax liabilities, leaving him with 28,999.418 shares of UnitedHealth common stock held directly.
ROOS THOMAS E reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 322 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 29,325 shares.
Zaetta Christopher R reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 213 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 10,115 shares.
McSweeney Erin reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 153 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 11,040 shares.
UnitedHealth Group Chief Executive Officer, UHC, Timothy John Noel reported a tax-related share disposition under a Form 4. On 02/13/2026, 125.616 shares of UnitedHealth Group common stock were used to cover tax withholding at a price of $293.19 per share. Following this tax-withholding disposition, he directly owned 9,205.052 shares of common stock.
UnitedHealth Group executive Patrick H. Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On February 13, 2026, a Form 4 shows a code F tax-withholding disposition of 295.409 shares of UnitedHealth Group common stock at $293.19 per share. After this transaction, Conway directly beneficially owned 10,308.506 shares of common stock.
UnitedHealth Group director equity compensation reported
A Form 4 reports that director Paul R. Garcia received equity-based compensation from UnitedHealth Group Inc. (UNH) on 01/02/2026. The filing shows a grant of 168 deferred stock units at a price of $0, described as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be held until his Board service ends. The filing also shows a separate grant of 112 shares of common stock at $0, also as regular quarterly director compensation. Following these transactions, he beneficially owns UnitedHealth Group common stock directly and indirectly, including shares held through several trusts.
UnitedHealth Group director reports quarterly equity compensation grant
A UnitedHealth Group director reported receiving 285 shares of common stock on 01/02/2026 at a price of $0, reflecting a grant of deferred stock units as regular quarterly compensation for Board service. After this grant, the director beneficially owns 10,160 shares directly and 6,033 shares indirectly through a trust. The deferred stock units are immediately vested but must be held until the director’s service on the Board is completed.
UnitedHealth Group reported an insider equity transaction involving one of its directors. On 01/02/2026, the director received 168 shares of common stock, described as a regular quarterly compensation grant for board service. The shares were acquired at a stated price of $0, reflecting that they are part of non-cash director compensation rather than an open-market purchase.
Following this grant, the director beneficially owns 2,075 shares of UnitedHealth Group common stock directly and 3,800 shares indirectly through a trust. The filing records the transaction as an acquisition of common stock and confirms it is being reported by a single reporting person.
UnitedHealth Group director reports quarterly equity compensation. Director John H. Noseworthy M.D., a board member of UnitedHealth Group Inc., reported receiving 261 shares of common stock on 01/02/2026 at a stated price of $0.
According to the disclosure, these are deferred stock units granted as regular quarterly compensation for service as a director. The units are immediately vested but must be held until the director’s service on the Board is completed. After this grant, the director beneficially owns 6,997 shares directly.
UnitedHealth Group director reports quarterly equity grant
A director of UnitedHealth Group received 279 deferred stock units of common stock on 01/02/2026 as regular quarterly compensation for Board service. These deferred stock units vest immediately but must be held until the director’s service on the Board is completed. Following this grant, the director beneficially owns a total of 7,219 shares or units of UnitedHealth Group common stock, held directly.